Angina : Who needs it? cardioprotection in the preconditioning eraDANA, A; YELLON, D. M.Cardiovascular drugs and therapy. 1998, Vol 12, Num 6, pp 515-528, issn 0920-3206Article

PTEN, the Achilles' heel of myocardial ischaemia/ reperfusion injury?MOCANU, M. M; YELLON, D. M.British journal of pharmacology. 2007, Vol 150, Num 7, pp 833-838, issn 0007-1188, 6 p.Article

Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanismEBRAHIM, Z; BAXTER, G. F; YELLON, D. M et al.Cardiovascular drugs and therapy. 2004, Vol 18, Num 2, pp 127-134, issn 0920-3206, 8 p.Article

Time course of delayed myocardial protection after transient adenosine A₁-Receptor activation in the rabbitBAXTER, G. F; YELLON, D. M.Journal of cardiovascular pharmacology. 1997, Vol 29, Num 5, pp 631-638, issn 0160-2446Article

Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioningIMAGAWA, J; YELLON, D. M; BAXTER, G. F et al.British journal of pharmacology. 1999, Vol 126, Num 3, pp 701-708, issn 0007-1188Article

Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B₂ receptor activation in human heartMORRIS, S. D; YELLON, D. M.Journal of the American College of Cardiology. 1997, Vol 29, Num 7, pp 1599-1606, issn 0735-1097Article

Inability of dimethylthiourea to limit tissue necrosis during acute myocardial infarction in rabbitsKINGMA, J. G; YELLON, D. M.Free radical biology & medicine. 1992, Vol 12, Num 4, pp 263-270, issn 0891-5849Article

Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dogKINGMA, J. G. JR; YELLON, D. M.Cardiovascular drugs and therapy. 1988, Vol 2, Num 3, pp 313-323Article

Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanismYAMASHITA, N; BAXTER, G. F; YELLON, D. M et al.Heart (London 1996). 2001, Vol 85, Num 3, pp 331-336, issn 1355-6037Article

Protecting the ischaemic and reperfused myocardium in acute myocardial infarction : distant dream or near reality?YELLON, D. M; BAXTER, G. F.Heart (London 1996). 2000, Vol 83, Num 4, pp 381-387, issn 1355-6037Article

Sulfonylurea K_ATP blockade in type II diabetes and preconditioning in cardiovascular disease : Time for reconsiderationENGLER, R. L; YELLON, D. M.Circulation (New York, N.Y.). 1996, Vol 94, Num 9, pp 2297-2301, issn 0009-7322Article

Ischaemic preconditioning of myocardium : a new paradigm for clinical cardioprotection ?BAXTER, G. F; YELLON, D. M.British journal of clinical pharmacology. 1994, Vol 38, Num 5, pp 381-387, issn 0306-5251Article

Changes in myocardial collagen content after chronic doca-salt hypertension in the ratBAXTER, G. F; YELLON, D. M.Medical science research. 1992, Vol 20, Num 14, pp 527-529, issn 0269-8951Article

Heat stress proteins and their relationship to myocardial protectionCARROLL, R; YELLON, D. M.Handbook of experimental pharmacology. 1999, Vol 136, pp 265-279, issn 0171-2004Article

Increased endogenous catalase activity caused by heat stress does not protect the isolated rat heart against exogenous hydrogen peroxideSTEARE, S. E; YELLON, D. M.Cardiovascular research. 1994, Vol 28, Num 7, pp 1096-1101, issn 0008-6363Article

Attenuation of reperfusion-induced ventricular fibrillation in the rat isolated hypertrophied heart by preischemic diltiazem treatmentBAXTER, G. F; YELLON, D. M.Cardiovascular drugs and therapy. 1993, Vol 7, Num 2, pp 225-231, issn 0920-3206Article

The protective effects of heat stress against reperfusion arrhythmias in the ratSTEARE, S. E; YELLON, D. M.Journal of molecular and cellular cardiology. 1993, Vol 25, Num 12, pp 1471-1481, issn 0022-2828Article

Stress proteins and myocardial protectionYELLON, D. M; LATCHMAN, D. S.Journal of molecular and cellular cardiology. 1992, Vol 24, Num 2, pp 113-124, issn 0022-2828Article

Targeting residual cardiovascular risk : raising high-density lipoprotein cholesterol levelsHAUSENLOY, D. J; YELLON, D. M.Heart (London 1996). 2008, Vol 94, Num 6, pp 706-714, issn 1355-6037, 9 p.Article

Targeting residual cardiovascular risk : raising high-density lipoprotein cholesterol levelsHAUSENLOY, D. J; YELLON, D. M.Postgraduate medical journal. 2008, Vol 84, Num 997, pp 590-598, issn 0032-5473, 9 p.Article

Ischaemic preconditioning : from mechanisms to exploitationWALKER, D. M; YELLON, D. M.Cardiovascular research. 1992, Vol 26, Num 8, pp 734-739, issn 0008-6363Article

Preconditioning the human myocardium : recent advances and aspirations for the development of a new means of cardioprotection in clinical practiceJENKINS, D. P; STEARE, S. E; YELLON, D. M et al.Cardiovascular drugs and therapy. 1995, Vol 9, Num 6, pp 739-747, issn 0920-3206Article

Adenosine-induced increase in myocardial ATP: are there beneficial effects for the ischaemic myocardium?HOHFELD, T; HEARSE, D. J; YELLON, D. M et al.Basic research in cardiology. 1989, Vol 84, Num 5, pp 499-509, issn 0300-8428, 11 p.Article

Myocardial adaptation to ischaemia : the preconditioning phenomenonCARROLL, R; YELLON, D. M.International journal of cardiology. 1999, Vol 68, pp 93-101, issn 0167-5273, SUP1Article

Adenosine A₁ receptor induced delayed preconditioning in rabbits : Induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanismDANA, A; SKARLI, M; PAPAKRIVOPOULOU, J et al.Circulation research. 2000, Vol 86, Num 9, pp 989-997, issn 0009-7330Article